Citation Impact
Citing Papers
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
2015
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Target gene selectivity of hypoxia-inducible factor-α in renal cancer cells is conveyed by post-DNA-binding mechanisms
2007 StandoutNobel
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
The urgent need to recover MHC class I in cancers for effective immunotherapy
2016
Prevention of cervical cancer through papillomavirus vaccination
2004
Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
2015
Myeloid-derived suppressor cells coming of age
2018 Standout
Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma
2003 StandoutNobel
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
2005 Standout
An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia
2006
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Regulation of cellular immune responses by selenium
1992
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
2016
Cancer immunotherapy via dendritic cells
2012 Standout
A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
2003 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cancer stem cells revisited
2017 Standout
Epigenetics in Cancer: A Hematological Perspective
2016
MAP kinase signalling pathways in cancer
2007 Standout
Induction of T Regulatory Cells Attenuates Idiopathic Nephrotic Syndrome
2008 Standout
Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens
1993
Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes
1990
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor
2004 StandoutNobel
Adipokine regulation of colon cancer: Adiponectin attenuates interleukin‐6‐induced colon carcinoma cell proliferation via STAT‐3
2010
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast
2001 StandoutNobel
Tumor Microenvironment and Myeloid-Derived Suppressor Cells
2012
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Genetic Analysis of the Role of the Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-inducible Factor (HIF) in Regulating HIF Transcriptional Target Genes
2004 StandoutNobel
Vaccination with human papillomavirus type 16-derived peptides using a tattoo device
2009
A novel quasi-viral agent, MaTu, is a two-component system
1992
Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical Trials
1996
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
1998 Standout
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
2008 StandoutNobel
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Preparation of Clinical‐Grade Recombinant Canarypox–Human Immunodeficiency Virus Vaccine–Loaded Human Dendritic Cells
2002 StandoutNobel
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
The therapeutic potential of carbon monoxide
2010 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Therapeutic Applications of Bilirubin and Biliverdin in Transplantation
2007
Contrasting effects of cyclophosphamide on anti‐CTL ‐associated protein 4 blockade therapy in two mouse tumor models
2017
Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin.
2013
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.
2001
New Approaches to Immunotherapy for HPV Associated Cancers
2011
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
2001 StandoutNobel
Kinase Suppressor of Ras (KSR) Is a Scaffold Which Facilitates Mitogen-Activated Protein Kinase Activation In Vivo
2002
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies
2015
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
2001 StandoutNobel
Myeloid‐derived suppressor cell heterogeneity in human cancers
2014
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
2020
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
2002 StandoutNobel
Carbonic Anhydrase (CA IX) Expression, a Potential New Intrinsic Marker of Hypoxia: Correlations with Tumor Oxygen Measurements and Prognosis in Locally Advanced Carcinoma of the Cervix 1
2001 StandoutNobel
Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.
1992
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Ex vivogeneration of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
2015
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
2016
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
2000 StandoutNobel
LF15-0195 generates tolerogenic dendritic cells by suppression of NF-κB signaling through inhibition of IKK activity
2003
The Ability of Two Listeria monocytogenes Vaccines Targeting Human Papillomavirus-16 E7 to Induce an Antitumor Response Correlates with Myeloid Dendritic Cell Function
2004
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of M Indrová being referenced
Tumour-Inhibitory Effects of Dendritic Cells Administered at the Site of HPV 16-Induced Neoplasms
2002
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
2011
Loss of Tumorigenicity of Murine Colon Carcinoma MC38/0 Cell Line after Transduction with a Retroviral Vector Carrying Murine IL-12 Genes
2004
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
2005
Cyclophosphamide-induced Myeloid-derived Suppressor Cell Population Is Immunosuppressive But Not Identical to Myeloid-derived Suppressor Cells Induced By Growing TC-1 Tumors
2012
Lymphokine-activated killer (LAK) cells: I. Age-dependent decline of LAK cell-mediated cytotoxicity
1987
Cancer immunotherapy using local interleukin 2 administration
1987
Therapy for minimal residual tumor disease: β‐Galactosylceramide inhibits the growth of recurrent HPV16‐associated neoplasms after surgery and chemotherapy
2009
Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen‐processing machinery components in a murine model for human papilloma virus 16‐associated tumours
2007
Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes
2014
Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations
1983
Phorbol myristate acetate-stimulated production of interleukin 2 by T-cell lymphoma and constitutive production by derived hybridomas.
1984
A Transmissible Antigen Detected in Two Cell Lines Derived from Human Tumours
1974
The potential immunosuppressive effect of bilirubin.
1988
DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment
2014
Recombinant interleukin-2 inhibits growth of human tumor xenografts in congenitally athymic mice
1987
Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide.
2001
Tumour vaccines expressing IL-2, CD80, and IL-2 plus CD80 gene
1997